Erin Johansson
Director HEOR Obesity, International Value and Access, Eli Lilly and Company
Erin Johansson is listed as Director HEOR Obesity, International Value and Access, Eli Lilly and Company. Erin spoke at ISPOR Europe 2026 in November 2026 (moderator, “From HTA to Public Health: Rethinking Value in Obesity”). Speaks mainly at Government Administration events.
Compiled from published conference agendas; not yet confirmed by Erin. Is this you? Claim this profile.
- Sector: Government Administration
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- From HTA to Public Health: Rethinking Value in Obesity Moderator · 9 November 2026
Spoke alongside
People who have shared a session with Erin at events on B2DB.
- Lieven Annemans Senior Full Professor Economics of Health and Wellbeing · Ghent University 1 shared session
- Olivia Wu University of Glasgow 1 shared session
- Michal Pochopien Co-founder, Senior Principal Consultant, Economic Modelling · Clever-Access 1 shared session
Others from Eli Lilly and Company
- Ana Tanaka Associate Director Global Treasury 1 session
- Jenny Laird VP, Business Development - Neuroscience 1 session
- Matthew Coghlan Vice President - External Innovation & Data Science - Diabetes Obesity & Cardiometabolic TA 1 session
- TiJuan Lumpkin Associate Vice President Collaboration & Mobility 1 session